Prevalence of metabolic syndrome in pre- and postmenopausal women
Arch. endocrinol. metab. (Online); 61 (2), 2017
Publication year: 2017
ABSTRACT Objective The objective of this study was to determine the prevalence of metabolic syndrome (MS) and its components among pre- and postmenopausal women, as well as the association between menopausal status and MS. Materials and methods A retrospective study was conducted at a reference cardiology outpatient clinic in a city located in Northwestern Paraná State, Brazil. A total of 958 medical records of symptomatic climacteric women evaluated between 2010 and 2014 were analyzed.
The study consisted of two groups:
pre- and post-menopausal women. MS was characterized according to the criteria of the National Cholesterol Education Program’s Adult Treatment Panel III – NCEP-ATP III-2005. Results MS was observed in 18.5% of the total study population; 9.4% of the premenopausal women and 22.2% of the postmenopausal women displayed MS, corresponding to a relative risk of 2.75. In addition, the frequency of MS increased with age. Regarding the components of MS, postmenopausal women were more likely to have high density lipoprotein (HDL-C) levels < 50 mg/dL; systolic blood pressure (SBP) values ≥ 130 mmHg or diastolic blood pressure (DBP) values ≥ 85 mmHg; and fasting glucose levels ≥ 100 mg/dL. Conclusion MS was more prevalent among postmenopausal women than among premenopausal women.
Distribución por Edad, Factores de Edad, Glucemia/análisis, Presión Sanguínea/fisiología, Brasil/epidemiología, Colesterol/sangre, Hipercolesterolemia/epidemiología, Hipertensión/epidemiología, Hipertrigliceridemia/epidemiología, Síndrome Metabólico/epidemiología, Posmenopausia, Premenopausia, Prevalencia, Estudios Retrospectivos, Medición de Riesgo, Factores de Riesgo, Triglicéridos/sangre